""BA.3.2 mutations in the spike protein have the potential to reduce protection from a previous infection or vaccination," CDC researchers said in the Morbidity and Mortality Weekly Report."
""We will have to watch this very carefully in the real world, because if this is a variant that develops the capacity to spread, it likely will influence what it is that we put into the vaccine," explained Dr. William Schaffner."
""We have to have a global horizon. What's over there can be over here in 24 hours," he said."
The COVID-19 BA.3.2 variant, first detected in a traveler at SFO, is spreading across the U.S. and 23 other countries. This variant has mutations that may help it evade immune responses, raising concerns about its impact on public health. Genomic surveillance is crucial for tracking its evolution. Experts note that while this variant is different from previous strains, its ability to infect lung cells is still under investigation. Public health measures must adapt to potential risks posed by such variants.
Read at SFGATE
Unable to calculate read time
Collection
[
|
...
]